Intas Biopharmaceuticals Limited, a amalgamated public limited company, was established on 23 November 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ2005PLC047111. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹22.42 Cr and a paid-up capital of ₹7.92 Cr.
Its leadership includes Urmish Hasmukh Chudgar (Managing Director), Sanjiv Dwarkanath Kaul (Director), Hasmukh Chudgar (Director). Past directors included Urmish Hasmukh Chudgar, Nitin Jagannath Deshmukh, Sanjiv Dwarkanath Kaul. Its latest AGM occurred on 21 August 2012, with the balance sheet filed on 31 March 2012. It is based at Plot No. 423 / P / A, Sarkhej-Bavla Highway, Moraiya, Tal. Sanand,, Ahmedabad, Gujarat, 382213.
U24230GJ2005PLC047111
047111
23 November 2005
₹22.42 Cr
₹7.92 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Intas Biopharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Urmish Hasmukh Chudgar | Managing Director | 23 Nov 2005 | Current |
| Sanjiv Dwarkanath Kaul | Director | 02 Aug 2011 | Current |
| Hasmukh Chudgar | Director | 16 Jan 2006 | Current |
| Binish Hasmukh Chudgar | Director | 08 Jul 2010 | Current |
| Nimish Hasmukh Bhai Chudgar | Director | 16 Jan 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Nov 2007 | Past |
| Pramod Abcsdd | Director | 11 Nov 2010 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2011 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Jul 2010 | Past |
| Pramod Abcsdd | Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Intas Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Intas Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Intas Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Intas Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Intas Biopharmaceuticals Limited last Annual general meeting of members was held on 21 Aug 2012 as per latest MCA records. was recorded as a recent event.
The activity Intas Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Ahmedabad. was completed.
Sanjiv Dwarkanath Kaul was appointed as a Director was appointed as a Director on 02 Aug 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.
The activity Jitesh Kumar Laddha was appointed as a Company Secretary was appointed as a Company Secretary on 27 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
Progress on Binish Hasmukh Chudgar was appointed as a Director was appointed as a Director on 08 Jul 2010 & has been associated with this company since 15 years 4 months . was documented.
The activity Hasmukh Chudgar was appointed as a Director was appointed as a Director on 16 Jan 2006 & has been associated with this company since 19 years 10 months . was completed.
Both the drug associations and pharma companies responsible for mandating the requirement of obtaining NOC prior to the appointment.
The CIN of Intas Biopharmaceuticals Limited is U24230GJ2005PLC047111.
Intas Biopharmaceuticals Limited is headquartered at Plot No. 423 / P / A, Sarkhej-Bavla Highway, Moraiya, Tal. Sanand,, Ahmedabad, Gujarat, 382213.
Intas Biopharmaceuticals Limited was incorporated on 23 November 2005.
The current directors of Intas Biopharmaceuticals Limited are
The primary industry of Intas Biopharmaceuticals Limited is Pharma.
Intas Biopharmaceuticals Limited is unlisted.
The authorized capital of Intas Biopharmaceuticals Limited is ₹22.42 Cr, and the paid-up capital is ₹7.92 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX